Janus Henderson Group PLC Sells 284,068 Shares of Medidata Solutions Inc (MDSO)
Janus Henderson Group PLC cut its holdings in shares of Medidata Solutions Inc (NASDAQ:MDSO) by 32.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 598,096 shares of the company’s stock after selling 284,068 shares during the quarter. Janus Henderson Group PLC owned approximately 1.02% of Medidata Solutions worth $46,687,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in MDSO. Fortaleza Asset Management Inc. bought a new stake in shares of Medidata Solutions during the third quarter valued at about $155,000. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Medidata Solutions by 10.5% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,186 shares of the company’s stock valued at $171,000 after buying an additional 208 shares during the period. Polen Capital Management LLC bought a new stake in shares of Medidata Solutions during the third quarter valued at about $205,000. Cubist Systematic Strategies LLC bought a new stake in shares of Medidata Solutions during the second quarter valued at about $227,000. Finally, ETF Managers Group LLC bought a new stake in shares of Medidata Solutions during the second quarter valued at about $233,000. 97.52% of the stock is currently owned by institutional investors and hedge funds.
In related news, CFO Rouven Bergmann sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, November 30th. The shares were sold at an average price of $65.40, for a total value of $130,800.00. Following the transaction, the chief financial officer now directly owns 91,775 shares in the company, valued at $6,002,085. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Michael I. Otner sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $70.88, for a total transaction of $708,800.00. Following the completion of the transaction, the executive vice president now owns 80,674 shares in the company, valued at $5,718,173.12. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 237,010 shares of company stock worth $16,305,136. 5.80% of the stock is owned by company insiders.
Medidata Solutions (NASDAQ:MDSO) last posted its quarterly earnings data on Thursday, October 26th. The company reported $0.33 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.31 by $0.02. The company had revenue of $140.08 million for the quarter, compared to analysts’ expectations of $141.27 million. Medidata Solutions had a net margin of 7.84% and a return on equity of 11.54%. Medidata Solutions’s revenue for the quarter was up 16.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.28 earnings per share. analysts anticipate that Medidata Solutions Inc will post 0.78 EPS for the current year.
Several equities research analysts have recently weighed in on MDSO shares. Dougherty & Co upgraded Medidata Solutions from a “neutral” rating to a “buy” rating and set a $75.00 price target on the stock in a research report on Monday, November 13th. Zacks Investment Research cut Medidata Solutions from a “hold” rating to a “sell” rating in a research report on Thursday, November 2nd. Royal Bank of Canada reiterated a “hold” rating and set a $80.00 price target on shares of Medidata Solutions in a research report on Friday, October 27th. KeyCorp reiterated a “buy” rating and set a $86.00 price target on shares of Medidata Solutions in a research report on Sunday, September 17th. Finally, Wells Fargo & Company decreased their price target on Medidata Solutions from $83.00 to $80.00 and set a “market perform” rating on the stock in a research report on Friday, October 27th. Four investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Medidata Solutions has a consensus rating of “Buy” and a consensus target price of $84.54.
Medidata Solutions Profile
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.
Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions Inc (NASDAQ:MDSO).
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.